Relief All Round as FDA Clears NeoTract’s UroLift® Prostate Implant

NeoTract, Inc. Receives U.S. FDA De Novo Approval for the UroLift® Prostate Implant (via PR Newswire)

Breakthrough Technology Approved for Treatment of BPH Delivers Durable and Effective Symptom Relief while Preserving Sexual Function PLEASANTON, Calif., Sept. 16, 2013 /PRNewswire/ — NeoTract, Inc., today announced that it received De Novo approval…